Safety and Antibody Response After 1 and 2 Doses of BNT162b2 mRNA Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant-Reference-Cited by-同舟云学术

Safety and Antibody Response After 1 and 2 Doses of BNT162b2 mRNA Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant

Published:2021-09-14 Issue:9 Volume:4 Page:e2126344
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Le Bourgeois Amandine¹,Coste-Burel Marianne²,Guillaume Thierry¹³,Peterlin Pierre¹,Garnier Alice¹,Béné Marie C.³⁴,Chevallier Patrice¹³

Affiliation:

1. Hematology Department, Nantes University Hospital, Nantes, France

2. Virology Department, Nantes University Hospital, Nantes, France

3. Institut National de al Santé et de la Recherche Médicale, Unité Mixte Recherche 1232, Centre de Recherche en Cancérologie et Immunologie Nantes Angers Institut de Recherche en Santé de l’Université de Nantes, University of Nantes, France

4. Hematology Biology, Nantes University Hospital, Nantes, France

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2784061/le_bourgeois_2021_ld_210194_1630679172.78541.pdf

Reference6 articles.

1. Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study.;García-Suárez;J Hematol Oncol,2020

2. Risk factors for a severe form of COVID-19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM-TC) multicentre cohort study.;Xhaard;Br J Haematol,2021

3. Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates.;Walsh;N Engl J Med,2020

4. Safety and immunogenicity of a first dose of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem-cells recipients.;Chevallier;EJHaem,2021

5. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients.;Boyarsky;JAMA,2021

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular and humoral immunogenicity against SARS-CoV-2 vaccination or infection is associated with the memory phenotype of T- and B-lymphocytes in adult allogeneic hematopoietic cell transplant recipients;International Journal of Hematology;2024-06-06

2. Monitoring Humoral Response Following BNT162b2 mRNA Vaccination against SARS-CoV-2 in Hematopoietic Stem-Cell Transplantation Patients: A Single-Center Prospective Study along with a Brief Review of Current Literature;Hematology Reports;2024-04-16

3. Severe acute respiratory syndrome coronavirus 2 infection in hematopoietic stem cell transplant recipients in Mexico City;Transplant Infectious Disease;2024-04-04

4. Pre-Exposure Prophylaxis and Treatment with Tixagevimab/Cilgavimab for COVID-19 among Immunocompromised Pediatric Patients;Journal of Clinical Medicine;2024-03-31

5. Comparable CD8⁺ T‐cell responses to SARS‐CoV‐2 vaccination in single‐cell transcriptomics of recently allogeneic transplanted patients and healthy individuals;Journal of Medical Virology;2024-03